comparemela.com
Home
Live Updates
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis : comparemela.com
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
Amended clinical collaboration and supply agreement increases the palazestrant/ribociclib combination Phase 1/2 clinical study size to approximately 60 patients Expanded study supports the potential...
Related Keywords
San Francisco ,
California ,
United States ,
Massachusetts ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Geoffrey Mogilner ,
Seanp Bohen ,
Securities Exchange ,
Exchange Commission ,
Novartis ,
Olema Pharmaceuticals Inc ,
Twitter ,
Novartis Institutes For Biomedical Research Inc ,
Nasdaq ,
Linkedin ,
Novartis Institutes ,
Biomedical Research ,
Chief Executive Officer ,
Securities Act ,
Securities Exchange Act ,
Quarterly Report ,
Vice President ,
Investor Relations ,
Markets ,
comparemela.com © 2020. All Rights Reserved.